Creative Medical Technology Holdings, Inc. (CELZ) stock
CELZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/30
$0.47−0.01 (-2.16%)
Close on Nov 18, 2026Market cap $3.07MP/E –Yield –
Creative Medical Technology price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Creative Medical Technology's price to sales ratio was 488.5× on Jun 30, 2025, against 251.7× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Jun 30, 2025 | 488.5× | +209.2 |
| 2024 | Dec 31, 2024 | 279.3× | +18.6 |
| 2023 | Dec 29, 2023 | 260.7× | −128.7 |
| 2022 | Dec 30, 2022 | 389.4× | – |
See a number that looks wrong?